Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJarvis Securities Regulatory News (JIM)

Share Price Information for Jarvis Securities (JIM)

Share Price is delayed by 15 minutes
Get Live Data
9.00    0.00 (0.00%)
Bid:
8.00
Ask:
10.00
Spread: 2.00 (25.00%)
Market Cap: £4.03m
JIM Live PriceLast checked at - London Stock Exchange

Intraday Jarvis Securities Share Chart

Board Change/Director Dealing

7 Feb 2008 09:41

Jarvis Securities plc07 February 2008 Jarvis Securities plc ("Jarvis" or "the Company") Board Change/Director's Shareholding/Transaction in Own Shares Jarvis Securities plc, the administration and outsourcing operation whichsupplies retail execution only stock broking facilities as well as outsourcedinvestment services and Model B settlement, is pleased to announce theappointment of Graeme McAusland B.Sc to the Board as a Non-Executive Directorwith effect from 1 March 2008. Graeme (aged 42) has held a number of senior positions and is on the Board ofThe Children's Mutual where he holds the post of Chief Operating Officerresponsible for all financial and governance areas including compliance, riskmanagement and audit functions. He has implemented and managed a number of newoperating and business models to enhance and increase the scale of business,having previously held the position of Financial Director and Appointed Actuary. Prior to this, Graeme held various management roles including Head of CorporateDevelopment with Prudential plc and is a Fellow of the Faculty of Actuaries. Graeme owns no shares or options in the Company at the present time. The following information is disclosed pursuant to Rule 17, Schedule Two (g) ofthe AIM Rules for Companies: Current Appointments Tunbridge Wells Insurance Services Limited Tunbridge Wells Equitable Investments Company Limited Tunbridge Wells Equitable Services Company Graeme is also a member of the Management Board of the Tunbridge Wells EquitableFriendly Society Limited There is no further information to disclose. Commenting on the appointment of Graeme to the Board, Andrew Grant, Chairman andChief Executive said: "We are delighted that Graeme has agreed to join the Board of Jarvis. He willbring his undoubted personal drive and expertise to enhance the Company'sstrategy and operations" John Mackay, who has been a non-Executive Director of the Company since 2004,has in view of his other business commitments agreed to stand down as anon-Executive Director effective from 29 February 2008. John has been veryhelpful to us over the last 3 years and we would like to thank him for hiscontribution to the Company's development and wish him well for the future. On 5 February, prior to John's departure, he exercised Options previouslygranted to him under the 2004 scheme pursuant to which he has acquired 50,000Ordinary Shares at a price of 82.5p per share. Following this purchase, John isbeneficially interested in 50,000 Ordinary Shares representing approximately 0.4per cent. of the Company's current issued share capital. The shares have beensatisfied from Treasury. The Company announces that between 1 February 2008 and 6 February 2008 itacquired 49,000 shares at an average price of 200.562p to be held in Treasury.Following these transactions and the sale of shares to Mr Mackay, the Companynow holds nil Ordinary Shares in Treasury and has 10,800,000 Ordinary Shares inissue. For further information: Jarvis Securities plcAndrew Grant, Chairman & CEO Tel: 0870 224 1111 Daniel Stewart & Company plcLindsay Mair/Tessa Smith Tel: 020 7776 6550 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Jul 20137:00 amRNSInterim Results and Dividend Declaration
18th Jul 201311:44 amRNSAdditional Listing and Total Voting Rights
29th May 20137:00 amRNSExercise of Options
15th May 20134:07 pmRNSExercise of Options
14th May 20137:00 amRNSTrading Update and Dividend Declaration
29th Apr 20139:30 amRNSExercise of Options
25th Apr 20139:05 amRNSDirector's Interest
21st Mar 20139:20 amRNSResult of AGM
12th Mar 20134:19 pmRNSExercise of Options and Director's Interest
25th Feb 20132:47 pmRNSExercise of Options and Director's Interest
21st Feb 20137:00 amRNSFinal Results
19th Feb 20137:00 amRNSExercise of Options
14th Feb 20132:47 pmRNSExercise of Options
13th Feb 20137:00 amRNSDividend Declaration
5th Feb 20133:50 pmRNSCorrection: Exercise of Options
5th Feb 201311:58 amRNSExercise of Options
10th Jan 20137:00 amRNSSale of Investment in Hubwise Holdings Limited
9th Jan 20133:30 pmRNSExercise of Options
11th Dec 20127:00 amRNSDirector's Interest
7th Dec 20129:01 amRNSDirector's Interest
20th Nov 20127:00 amRNSDirector/PDMR Shareholding
14th Nov 201212:18 pmRNSDividend Declaration
12th Nov 201212:18 pmRNSDirector/PDMR Shareholding
23rd Oct 20127:00 amRNSDirector/PDMR Shareholding
17th Sep 20124:24 pmRNSExercise of Options
12th Sep 201211:12 amRNSExercise of Options
26th Jul 20127:01 amRNSDividend Declaration
26th Jul 20127:00 amRNSInterim Results
23rd Jul 20125:24 pmRNSAdditional Listing
2nd Jul 20127:00 amRNSDirectorate Change
21st Jun 20127:00 amRNSChange of Adviser
10th May 20122:23 pmRNSAdditional Listing
9th May 20123:31 pmRNSDividend Declaration
22nd Mar 201212:12 pmRNSResult of AGM
28th Feb 20123:13 pmRNSAdditional Listing
28th Feb 20122:45 pmRNSDirector/PDMR Shareholding
28th Feb 20129:04 amRNSAdditional Listing
23rd Feb 201211:15 amRNSDirector/PDMR Shareholding
23rd Feb 201210:38 amRNSDividend - amendment to DRIP date
22nd Feb 201212:06 pmRNSDividend Declaration
22nd Feb 20127:00 amRNSFinal Results, Annual report and AGM Notice
1st Feb 20127:00 amRNSChange of Name of Nominated Adviser and Broker
28th Dec 20112:49 pmRNSDirector/PDMR Shareholding
6th Dec 20113:55 pmRNSDirector's Dealing
11th Nov 20113:34 pmRNSReplacement - Dividend Declaration
11th Nov 201111:01 amRNSDividend Declaration
17th Aug 201110:51 amRNSDirectors' Dealing
26th Jul 201112:02 pmRNSReplacement - Interim Results
26th Jul 20117:00 amRNSInterim Results - Six months ended 30 June 2011
20th Jul 20117:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.